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Highlights 
- Frailty is prevalent in CKD patients with those on dialysis being the most frail  
- Frailty is associated with an increased risk of mortality and hospitalization 
- Most common method of frailty assessment in the CKD cohort is the Fried phenotype  
- Reported frailty prevalence changes depending on the method of frailty assessment  
Abstract  
Objective: Frailty is associated with increased vulnerability to poor health. There is growing interest in 
understanding the association between frailty and chronic kidney disease (CKD). This systematic 
review explored how frailty is measured in patients with CKD and the association between frailty and 
adverse outcomes across different stages of renal impairment.  
Study design:  Systematic analysis of peer reviewed articles.  
Data Sources: Pubmed, Medline, Web of Science and Cochrane were used to identify the articles.  
Data synthesis: Articles published before the 17th of September 2016, that measured frailty in 
patients with CKD were eligible for the systematic review. Two independent researchers assessed the 
eligibility of the articles. Quality of the articles was assessed using the Epidemiological Appraisal 
Instrument.   
Results: The literature search yielded 540 articles, of which 32 met the study criteria and were 
included in the review (n=36 076, age range: 50 – 83 years). Twenty-three (72%) studies used or 
adapted the Fried phenotype to measure frailty. The prevalence of frailty ranged from 7% in 
community-dwellers (CKD Stages 1 – 4) to 73% in a cohort of patients on haemodialysis. The 
incidence of frailty increased with reduced glomerular filtration rate. Frailty was associated with an 
increased risk of mortality and hospitalization.  
Conclusion: Frailty is prevalent in patients with CKD and it is associated with an increased risk of 
adverse health outcomes. There are differences in the methods used to assess frailty and this hinders 
comparisons between studies.       
Keywords:  renal insufficiency, chronic; frail elderly 
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Introduction  
Frailty describes a state of increased vulnerability to health problems. There are two acknowledged 
conceptualisations of the term, which have resulted in different approaches to its measurement.1 
Firstly, frailty can be thought of as a syndrome with sarcopenia as the key pathophysiological feature2: 
this facilitates the measurement of frailty using a specific set of signs and symptoms. This approach, 
developed by Linda Fried, defines five criteria that establish a phenotype for frailty: slowness, 
weakness, low physical activity, exhaustion and shrinkage.2  
The second approach, known as the frailty index approach, views frailty as a state of deficit 
accumulation that begins at the cellular level and leads to a loss of redundancy in organ systems3-5; 
here, frailty is quantified by counting deficits across multiple systems.  
Patients who are frail, regardless of how it is measured, experience a decline in physical function and 
are at an increased risk of adverse health outcomes. Although there is a strong positive correlation 
between frailty and chronological age, patients with chronic disease also appear to be predisposed to 
frailty.6  
The relationship between chronic kidney disease (CKD) and frailty is not completely understood.  
Studies have shown that inflammation is associated with frailty in many chronic diseases and this 
suggests a ‘shared pathophysiology’ of frailty.3 In particular, the pro-inflammatory cytokines 
interleukin-6 and tumour necrosis factor alpha may have a role in age-related muscle atrophy and 
sarcopenia, which are key features of frailty.7 Shlipak et al8 demonstrated that there are raised levels 
of pro-inflammatory cytokines in CKD patients. However, further research is needed to investigate the 
causal relationship between inflammation and frailty specifically in patients with CKD.  
A previous systematic review (studies published to 2012) explored frailty in pre-dialysis patients and 
showed an association between frailty and CKD.9 Here, we update and expand this evidence, by 
including patients on dialysis as well as in kidney transplant recipients. The aims of the systematic 
review were to explore how frailty is measured in patients with CKD, evaluate the relationship 
4 
 
between frailty and severity of kidney failure and assess whether it predicts outcomes such as 
mortality and hospitalization.  
Method 
Search strategy  
The following search terms were used to identify articles that assessed frailty in patients with CKD:  
‘Chronic kidney disease’ OR ‘kidney disease’ OR ‘Renal Insufficiency’ OR ‘dialysis’ OR ‘kidney failure’ 
OR ‘renal failure’ AND ‘frailty’. 
The focus of this review was on assessment of frailty status. Thus, we did not broaden the search 
criteria for frailty to include geriatric or functional assessments. The literature search was conducted 
using online databases including Pubmed, Medline, Web of science and Cochrane libraries. The 
reference lists of key papers were also examined for articles of relevance. 
Selection criteria 
Inclusion criteria for the systematic review were primary research articles that analysed the 
prevalence of, or relationship between, frailty and CKD.  All studies investigating frailty in dialysis, pre-
dialysis and kidney transplant recipients published before 17th September 2016 were eligible for 
inclusion. Articles were excluded if they were not available in the English language. Where there were 
articles that involved different analyses on the same study population, the article that best answered 
the aims of the systematic review was selected for analysis.  
Data analysis 
Two independent reviewers examined the abstracts for relevance to the study criteria. Where there 
was a difference of opinion about inclusion of the study, a third reviewer was consulted. 
A data extraction table was created which included information about the demographics of the study 
population, the sample size, method of frailty assessment, CKD measurement and outcome variables 
such as mortality rates and hospitalization.  
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Each article in the systematic review was assessed for quality using the Epidemiological Appraisal 
Instrument (EAI). The EAI, developed by Genaidy and colleagues, provides a systematic appraisal of 
study quality across the domains of sample selection, exposures and outcomes, statistical analysis 
and adjustment for co-variates and confounders.10 Each domain was scored out of 2, and the average 
across the domains was expressed as the overall EAI score. The closer the score to 2 the better the 
article.   
Due to the significant heterogeneity in the sample populations, method of frailty assessment, and 
CKD measurement a meta-analysis was not performed.    
Results:  
The literature search yielded 540 articles. Forty-eight articles met the inclusion criteria and were 
selected for full text review. After the full text review a further 16 studies were excluded from further 
analysis for the following reasons: article did not measure frailty in the study population (n=3); not 
available in English (n=2); did not measure frailty in a CKD population (n=3); repeated analyses on 
the same study population (n=8); and one article whose results were not available for the systematic 
review.   This resulted in 32 studies that were included as part of the systematic review (Figure 1). 
Overall, there were 18 studies (56%) which were designed as primary prospective analyses of frailty 
in CKD. The remaining 14 studies (44%) were secondary analysis of established cohorts not originally 
sampled for examining frailty.  
Demographics of the Study Population 
Fifteen studies examined frailty in pre-dialysis patients with CKD, fourteen in the dialysis population 
and three in patients who had received kidney transplantation. These studies examined frailty in a 
total of 36 076 participants with CKD (82% in pre-dialysis patients and 18% in dialysis patients). The 
study characteristics and population demographics are reported in Tables 1 and 2.  
Critical Appraisal of Quality 
The average EAI score for the studies was 1.63 (Standard deviation – 0.18). The individual scores for 
each article are reported in Table 1 and 2. Overall, the articles performed well in describing the aims 
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and defining the exposure and outcome variables. However, most articles did not publish sample size 
calculations, participation rates or account for subjects lost to follow up – these criteria were three 
lowest achieved amongst those of the EAI.  
 
Method of Frailty Assessment 
The majority of studies classified frailty using the Fried phenotype (n=23, 72%). However, there were 
variations in the interpretation of the five characteristics of frailty compared to the original definitions 
stipulated by Fried et al (Table 3).2  
Estimation of physical activity and exhaustion showed the most heterogeneity between the studies. 
The most common methods of physical activity assessment were estimation of kilocalories (n=9, 
41%), patient self-report (n=8) and questionnaire based assessment (n=6). Exhaustion was 
determined most frequently by patient self-report (n=11, 48%), Short-Form 36 vitality score (n=6) and 
the Centre for Epidemiological Studies Depression Scale (n=5). Grip strength was the most common 
method of assessing weakness (n=14, 61%), whilst slowness was measured using timed gait speed 
(n=17, 74%). Shrinkage was estimated by measuring weight loss over 12 months (n=12, 52%).  
There were seven studies (30%) that modified the Fried criteria for frailty and substituted the 
measurement of grip strength and gait speed for questionnaire based assessments of physical 
function. This method improves the feasibility of investigating frailty in large sample populations.11 
However, Painter et al12 showed that using questionnaire based data over-estimated the reported 
prevalence of frailty in haemodialysis patients. 
Ten studies (31%) employed a different measure to the Fried phenotype for frailty assessment. The 
most common of these, used in three studies, was the Clinical Frailty Scale. This is a clinical 
assessment of frailty developed from the Canadian Study of Health and Aging, which ranks fitness 
from a score of 1 (Very fit) to a score of 8 (severely frail and unlikely to recover from a minor illness) to 
a score of 9 (terminally ill).13 Other scales used include the frailty index approach, which provides a 
quantitative assessment of frailty as the proportion of potential deficits in health.4 This has been 
shown to be reproducible and be predictive of outcomes.14 Chao et al uses the FRAIL scale (Fatigue, 
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Resistance, Ambulation, Illness, Loss of weight), which is related to the criteria developed by Fried et 
al but adds co-morbidity (illness) to self-reported assessment of the other criteria.15  Other measures 
used in the studies include the Groningen Frailty Indicator, Montensanto approach, Edmonton Frail 
Scale and a frailty check list.16-19  
 
Prevalence of Frailty 
Frailty was prevalent in patients with CKD, particularly in those on dialysis. Amongst the pre-dialysis 
population the prevalence of frailty ranged from 7%, in a study of community dwellers with CKD 
(median estimated glomerular filtration rate (eGFR) = 49mLs/min), to 42.6% in a smaller study of 
patients with more severe CKD (mean eGFR = 27mLs/min).20,21 A study by Rodriguez et al22 had no 
patients who were frail, despite the sample population having severe CKD (mean eGFR =16). 
However, patients in this study were referred into the clinic for consideration for dialysis; as a 
consequence of this screening process, only those who were ‘fit’ were selected.22   
Frailty was more prevalent amongst patients on haemodialysis with the range being from 14% to 
73%.23,24 There was no statistical comparison performed of the prevalence between dialysis and pre-
dialysis patients because of the differences in the methods used to assess frailty.  
Glomerular Filtration Rate and Frailty 
Six studies demonstrated a negative correlation between eGFR and the risk of frailty in pre-dialysis 
patients with CKD.20,25-29 Three of the six studies used cystatin C to estimate eGFR, two used 
creatinine and one use iodine 145-iothalamate clearance. A study by Roshanravan et al25 found that 
the relationship between frailty and CKD was attenuated when using creatinine instead of Cystatin C 
to estimate GFR. In five studies, there was significant increase in the risk of frailty with eGFR less 
than 45mLs per minute.20, 25-28 In the remaining study, only patients with an eGFR less than 30mLs 
per minute were at a statistically significant increased risk of frailty because those with an eGFR >45 
was used as the reference population.29    
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A study by Dalrymple et al27 in the Cardiovascular Health Study cohort showed that CKD was 
associated with an increased risk of incident frailty. Patients with CKD who did not have baseline 
frailty were followed for four years. The risk of developing frailty was inversely related to baseline 
eGFR.27 Patients with a eGFR between 15 and 45 mls/min were twice as likely to develop frailty over 
four years when compared with patients with normal eGFR.27    
 
Mortality, Hospitalization and Falls 
Eight studies assessed adverse health outcomes in frail patients with CKD: four in dialysis 
populations and four in pre-dialysis cohorts. Johansen et al30 examined frailty in dialysis patients and 
found an increased risk of death associated with frailty after one year of follow-up (Hazard Ratio [HR] 
2.24, 95% CI 1.6 – 3.15). Similarly, Bao et al23 and McAdams De-Marco et al31 reported a significant 
risk of mortality associated with frailty amongst the dialysis population. The relationship between 
frailty and risk of death persisted after multivariate adjustment for age, sex and co-morbidities in all 
three studies. Alfaadhel et al32 demonstrated that each one point increase in the Clinical Frailty Scale 
was associated with an increased risk of mortality in haemodialysis patients (HR 1.22 [95% CI 1.04-
1.13]; median follow-up: 1.7 years). Bao et al23 and McAdams De-Marco et al31 also demonstrated 
that frailty correlated with an increased risk of hospitalization in dialysis patients. An analysis of a 
composite end-point of death or hospitalization reached statistical significance in the study by 
Johansen et al (HR 1.56 95% CI 1.36-1.79).30      
Roshanravan et al25 conducted a study in patients with CKD stages 1-4 and demonstrated that frailty 
was an independent risk factor for death or progression to dialysis (HR: 2.5 [95% CI 1.4-4.4]; median 
follow-up: 2.6 years). In a study by Wilhelm-Leen et al26, frailty increased the risk of death in patients 
with CKD and the risk was only partly attenuated in a multivariate model that adjusted for co-
morbidities, inflammation and sarcopenia (HR 2.0 [95% CI 1.5 – 2.7]). Studies by Delgado et al29 and 
Pugh et al33 also demonstrated an increased risk of mortality in patients with pre-dialysis CKD who 
were frail.  
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Frailty is a risk factor for falls in patients with end stage kidney disease In a cohort of haemodialysis 
patients, McAdams De-Marco et al34 demonstrated that frailty increased the risk of falls by three times 
compared to those who were not frail (RR=3.09, 95% CI 1.38 – 6.90).   
Frailty and the Kidney Transplant Recipient 
Three studies have investigated frailty in kidney transplant recipients. McAdams De-Marco et al35 
demonstrated that incident frailty increased the risk of hospital readmission amongst kidney transplant 
recipients (Relative Risk= 1.61, 95% CI 1.18-2.19). This risk persisted after adjustment for age, 
gender, co-morbidity, time spent on dialysis and donor factors. Another study by Garonzik-Wang et 
al36 showed that frailty was an independent risk factor for delayed graft function (RR=1.94, 95% CI 
1.13-3.36). A second study by McAdams De-Marco37 investigated the change in frailty status after 
kidney transplantation. It found that the prevalence of frailty in the cohort decreased at 3 months of 
follow up and that patients who were frail before transplantation were twice as likely to have 
improvement in frailty score after transplantation (HR: 2.55 [95% CI: 1.71-3.82]).37 
Discussion  
In this systematic review of frailty in patients with CKD, the prevalence of frailty increased with poorer 
kidney function and was highest in patients receiving dialysis.  Frailty was a significant predictor of 
adverse health outcomes, particularly in those with severe CKD stages. However, we found 
differences in frailty assessment and estimation of GFR and this may have influenced the reported 
prevalence of frailty.  
The Fried phenotype provided the basis for frailty assessment in the majority of the studies in this 
review (n=23, 72%). This is a well validated method of frailty assessment that classifies patients as 
frail, pre-frail or not frail categories.2 However, the Fried phenotype is less useful in grading the 
severity of frailty in populations where the prevalence of frailty is high.38 This is particularly 
problematic in patients on dialysis with one study demonstrating the prevalence of frailty be as high as 
73%.23 Other methods, such as the frailty index, provide a continuous variable that may improve the 
discrimination of those patients at high risk, especially in patients on dialysis.39      
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The feasibility of using performance based tests of grip strength and slowness has proven to be 
problematic in retrospective studies that have used the Fried phenotype. One approach, proposed by 
Woods et al11, involves replacing performance based tests with questionnaire based data to grade 
loss of physical function.  However, the correlation between measuring grip strength and slowness 
versus estimating physical function using the SF-36 questionnaire is poor (r=-0.34 for gait speed; 
r=0.14 for grip strength).11 There were seven studies that modified the Fried phenotype and used the 
approach of using questionnaire data to replace the measured variables12,21,23,39,30,40,41. Subsequently, 
Painter et al12 conducted a comparison of measuring gait speed and grip strength versus 
questionnaire data in quantifying the prevalence of frailty in haemodialysis patients. The study found 
the prevalence of frailty was 24% in the performance based group and 78% in the group using 
questionnaire data.12 Thus the methods by which the characteristics of Fried’s phenotype of frailty are 
defined can considerably influence the prevalence of frailty in the population being investigated.  
GFR estimation was different amongst the studies and this may influence the relationship between 
frailty and severity of CKD. The most common method of deriving an eGFR is by creatinine clearance, 
as reported in 12 studies. However since this relies on muscle mass, the eGFR of frail patients who 
have lost muscle mass may be over-estimated. Another method of estimating GFR is by using 
cystatin C which is not influenced by muscle mass and this was utilised in three studies. The strength 
of the association between frailty and eGFR appears to be increased by using cystatin C.  
Regardless of the method of estimation, GFR seems to be an important mediator in the risk of frailty 
in patients with CKD. Five studies demonstrated that eGFR less than 45mLs/min was associated with 
increased odds of frailty.20, 25-28 There were differences in the calculation of the odds ratios because of 
different definitions of the eGFR of the reference population. This influenced the value of the odds 
ratios and prevented comparisons between studies.  
The prevalence of frailty ranged from 7% to 42.6% in pre-dialysis patients.20,21 Amongst dialysis 
patients, the highest prevalence of frailty in the studies analysed was 73%.23  However, there was a 
wide range of frailty prevalence in the various CKD populations included in this review. Differences in 
the demographics of the study population, average eGFR, gender, co-morbidities and ethnicity may 
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explain this difference. Furthermore, as demonstrated previously, the method of frailty assessment 
can considerably influence the proportion of patients classified as being frail.   
Patients with CKD who were frail were at increased risk of mortality and hospitalization. The risk of 
mortality was significant in both dialysis and pre-dialysis patients with CKD.23,25,26,29-33 Frailty also 
predicted an increased risk of falls in patients with CKD.34,42 In the kidney transplant recipient, frailty 
was associated with an increased risk of early hospital readmission and delayed graft function.35,36 
Patients who were frail prior to transplantation were also more likely to have improvement in frailty 
after transplantation.37 A previous systematic review by Walker et al9 found similar associations 
between frailty and adverse health outcome in patients with non-dialysis CKD. The association of 
frailty with mortality risk is consistent with other studies in community dwellers with normal renal 
function.5,11  
The findings of this systematic review have multiple implications for clinical practice. Firstly, it 
highlights the prevalence of frailty particularly in those with Stage 5 CKD and those on dialysis. 
Identifying these patients is important because frailty is associated with poor health outcomes. Frailty 
is a useful marker of health status and can be used to monitor response to interventions; an example 
of this can be seen in the study by McAdams de Marco and colleagues who explored how frailty 
status changed before and after kidney transplantation.37   
Whilst a number of the articles in this systematic review were primary prospective studies, there is 
little data commenting on the length of time to complete these frailty assessments or the resources 
needed. One study, investigating the frailty index, demonstrated that a frailty assessment is feasible in 
an outpatient CKD clinic and could be conducted in approximately 10 minutes using a questionnaire.39 
However, there is a need to compare different frailty assessment methods to establish which is better 
suited in a clinical setting. With the exception of kidney transplantation, there is no evidence for 
interventions that can change a patient’s frailty status if they have CKD. Frailty manifests when there 
is a critical number of deficits across multiple systems including those that regulate inflammation.7 
Thus, it is likely that multiple strategies will be needed in tackling this issue of frailty in patients with 
CKD.  
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There are strengths and limitations inherent in this systematic review. It encompasses a diverse range 
of populations with CKD including patients on dialysis, community dwellers who are not on dialysis 
and kidney transplant recipients. The total sample size is large with 36,000 patients.  However, 
differences in the method of frailty assessment and estimation of GFR between the studies meant 
there was considerable heterogeneity between studies. For this reason, a meta-analysis and 
summation statistics could not be performed to take full advantage of the large sample size. A large 
proportion of studies (n=14, 44%) used a secondary analysis in an existing cohort of patients to 
examine the relationship between frailty and CKD. This raises issues of external validity and whether 
the studies sufficiently addressed selection bias when presenting the findings. Unpublished results 
and a single article not available in the English language were excluded from this systematic review. 
Publication bias is a possibility because of exclusion of these studies.  
Conclusion 
Based on the number of studies, consistency and quality of the findings, there is strong evidence that 
frailty is associated with CKD and that patients with more severe CKD are more likely to be frail. 
Frailty predicts poor outcomes in patients with CKD including an increased risk of mortality and 
hospitalization. There is a need to better understand causality and why frailty is associated with 
adverse health outcomes in patients with CKD. Further research should also explore different 
methods of frailty assessment that better delineate those who are most frail and who may benefit from 
targeted intervention.  
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Figure 1: Study Selection 
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literature search 
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492 articles 
excluded for 
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the inclusion 
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full text review for replicated 
analysis or the same study 
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the inclusion criteria (see 
Appendix 1 for details of the 
excluded studies) 
  
Table 1: Pre-dialysis Patients 
Reference Study 
Characteristic
s 
Study 
Population 
Primary Outcome Study Design EAI Frailty 
assessment 
GFR 
estimation 
and Average 
GFR 
Frailty 
Prevalence 
Shlipak et al 
200443 
N = 648 
%female= 39 
Mean age = 
76 years 
Cardiovascula
r Health 
Study 
(enrolment)  
USA 
Investigate the prevalence and 
association of CKD with frailty and 
disability 
 
Secondary analysis of 
an established cohort. 
 
1.57 Fried  CrCl 
41mLs/min 
15% 
Dalrymple et al 
201327 
N = 4150 
%female = 59 
Mean age = 
75 years  
Cardiovascula
r Health 
Study (3 year 
review) 
USA 
Examined the prevalence and 
development of frailty in patients with 
incident CKD 
Secondary analysis of 
an established cohort 
 
 
 
1.67 Fried Cystatin 
C/CrCl 
73mLs/min 
(median GFR) 
9.7% 
Roshanravan 
et al 201225 
N = 336 
%female = 19 
Mean age = 
59 years (+/- 
13) 
 
Pre-dialysis 
CKD stages 1-
4 – 
Outpatients 
USA 
Prevalence and association of CKD with 
frailty. Measured outcomes including 
mortality and progression to dialysis 
 
Primary prospective 
study  
1.76 Fried Cystatin C 
51mLs/min 
14% 
Wilhelm-Leen 
et al 200926 
N = 10 256 
%female = 53 
Mean age = 
50 years (+/- 
1.3) 
National 
Health and 
Nutrition 
Evaluation 
Survey  
USA 
Correlation of frailty with CKD and 
mediators of this interaction 
 
Secondary analysis of 
an established cohort. 
 
 
1.81 
 
Fried CrCl 
106.21mLs/m
in (includes 
controls) 
7.9% 
Hart et al 
201328 
N = 1602 
%female = 0 
Mean age = 
74 years (+/- 
5.9) 
Osteoporotic 
fractures in 
men Study  
USA 
Association of frailty with CKD 
 
 
Secondary analysis of 
an established cohort 
 
 
1.67 Fried Cystatin 
C/CrCl 
Mean GFR 
not published 
Not 
published 
  
Mansur et al 
201421 
N = 61 
%female = 41 
Mean age = 
61 years (+/- 
11.5)  
Pre dialysis 
CKD patients 
Brazil 
Association between frailty, CKD and 
QOL in pre-dialysis patients. 
 
 
Primary prospective 
study 
1.19  Modified 
Fried 
CrCl 
27mLs/min 
42.6% 
Reese RP et al 
201320 
N = 1111 
%female = 47 
Median age = 
65 years (+/- 
8) 
Chronic renal 
insufficiency 
cohort 
USA 
Association between CKD severity and 
frailty and risk factors for frailty.  
 
Secondary analysis of 
an established cohort 
 
 
1.86 Fried CrCl 
49mLs/min 
(median GFR) 
7% 
Yamada et al 
201319 
N = 8063 
%female = 62 
Mean age = 
81 years (+/- 
7.4) 
J-MACC study 
– Community 
dwelling 
individuals  
Japan 
Risk of requiring long-term care 
insurance in frail patients with CKD 
 
Secondary analysis of 
an established cohort 
 
 
1.52 Frailty Check 
List 
CrCl 
Not published 
Not 
published 
McAdams De-
Marco et al 
201335 
N = 383 
%female = 40 
Mean age = 
54 years (+/- 
13.9) 
Renal 
transplant 
recipients 
USA 
Frailty as a risk factor for early hospital 
readmission post kidney transplant 
 
 
Primary prospective 
study 
1.76 Fried No GFR 
estimation 
18.8% 
Garonzik-
Wang et al 
201236 
N = 183 
%female = 36 
Mean age = 
53 years (+/-
14) 
Renal 
transplant 
recipients 
USA 
Association between frailty and 
delayed graft function in renal 
transplant recipients 
 
 
Primary prospective 
study 
1.52 Fried No GFR 
estimation 
25% 
McAdams De-
Marco et al 
201537 
N = 349 
%female = 
38.1 
Mean age = 
53.3 (+/- 
14.2) years 
Renal 
transplant 
recipients 
USA 
The natural trajectory of frailty before 
and after kidney transplantation. 
 
Primary prospective 
study 
1.67 Fried No GFR 
estimation 
19.8% (at 
baseline)  
Rodriguez et al 
201422 
N = 56 
%female = 
Pre-dialysis 
patients  
Exploring factors that influenced the 
decision for conservative care versus 
Primary prospective 
study 
1.57 Fried CrCl 
16mLs/min 
0%  
  
48.2 
Mean age = 
79 
(+/- 5) years 
Spain 
 
dialysis in older patients with Stage 4-5 
CKD.  
 
Lee et al 
201541 
N = 168 
%female = 37 
Mean age = 
65.9 years 
Pre-dialysis 
patients  
Korea 
Examine the prevalence of frailty and 
its influence on quality of life 
 
Primary prospective 
study 
1.67 Fried CrCl 
41.1mLs/min 
37.5% 
Montesanto et 
al 201418 
N = 1038 
%female = 
53.2 
Mean age = 
83.4 years 
Pre-dialysis 
patients 
Italy 
The relationship between frailty, GFR 
estimating using BIS1 equation and 
mortality. 
Secondary analysis of 
an established cohort 
1.86 Population 
based 
approach 
CrCl 
53mLs/min 
48.3% 
Meulendijks et 
al 201516 
 
N = 63 
%female = 35 
Median age = 
75 years 
Pre-dialysis 
patients 
Netherlands 
Evaluation of whether the Groningen 
Frailty Index can distinguish between 
fitter patients who may benefit from 
dialysis from frailer patients in need of 
geriatric assessment. 
Primary prospective 
study 
1.48 Groningen 
Frailty Index 
CrCl 
16mLs/min 
32% 
Hubbard et al 
201539 
N = 110 
%female = 
46.4 
Mean age = 
65.2 (+/- 
14.6) years 
Pre-dialysis 
patients  
Australia 
Pilot study investigating the feasibility 
of using the frailty index in patients 
with pre-dialysis chronic kidney 
disease. 
Cross sectional analysis of frailty  
Primary prospective 
study.  
1.76 Frailty index NA Mean FI = 
0.25 
Delgado et al 
201529 
N = 812 
%female = 
39.5 
Median age = 
52 years (42-
61 years IQR) 
 
MDRD  
Pre-dialysis 
patients 
USA 
Investigation of self-reported frailty 
and its association with GFR and 
mortality 
Prospective cohort study 
Secondary analysis of 
an established cohort 
1.67 Modified 
Fried 
CrCl 
Iodine 145-
iothalamate 
clearance 
33.1mLs/min 
16% 
Pugh et al 
201633 
N = 283 
%female = 
Pre-dialysis 
patients 
Relationship between frailty and co-
morbidity with the risk of mortality in 
Primary prospective 
study 
1.48 Clinical 
Frailty Scale 
CrCl 
16mLs/min 
33% 
  
44% 
Median age = 
74 (63-81 
years IQR) 
UK elderly patients referred to an 
outpatient chronic kidney disease 
clinic. 
 
 
 
Table 2: Dialysis Patients 
Study Study 
Characteristics 
Study Population Primary Outcome Study Design EAI Frailty 
Assessment  
Prevalence 
of frailty 
Bao 2012 et al23 N = 1576 
%female = 45 
Mean age = 59.6 
years 
Comprehensive Dialysis 
Study 
HD% = 89.3 
USA 
Frailty prevalence dialysis cohort. GFR 
at dialysis initiation and its relationship 
with frailty 
Secondary analysis 
of an established 
cohort 
1.62  Modified Fried 73% 
McAdams-
DeMarco et al 
201331 
N = 146  
%female = 47  
Mean age = 61 
years (+/- 13.6) 
Single haemodialysis 
centre 
HD% = 100 
USA 
Prevalence of frailty and outcome 
assessment  
Primary 
prospective study 
1.67 Fried 41.8% 
Delgado et al 
201340 
N = 80 
%female = 37  
Mean age = 55 
years (+/- 13) 
Nandrolone and Exercise 
Study 
HD% = 100 
USA 
A comparison of function based frailty 
assessment and performance based 
tests. Body composition and frailty 
status.   
Secondary analysis 
of an established 
cohort 
1.19 Modified Fried: 
Performance 
based and 
Function Based 
Criteria 
59% 
(performan
ce based) 
Painter et al 
201312 
N = 188 
%female = 56 
Mean age = 54.4 
(+/- 16) years 
Renal Exercise 
Demonstration Study 
HD% = 100 
USA 
Analysis of two methods of applying 
the Fried phenotype for frailty: 
questionnaire based physical function 
vs measurement  
Secondary analysis 
of an established 
cohort 
1.81 Fried 24% 
(measured 
physical 
function) 
Johansen et al 
200730 
N = 2275 
%female = 47 
Mean age = 58 
years (+/- 16) 
Dialysis 
Morbidity/Mortality 
Study 
HD% = 51.9 
Investigation of the prevalence and 
predictors of frailty amongst dialysis 
patients and correlation with adverse 
health outcomes.  
Secondary analysis 
of an established 
cohort 
1.71 Modified Fried 68% 
  
USA Prospective cohort study 
Kutner et al 
201424 
N = 742 
%female = 40.6 
Mean age = 57 
years (+/- 14.1) 
ACTIVE/ADIPOSE Study 
HD% = 100 
USA 
 
Frailty and its association with ADL 
difficulties 
Secondary analysis 
of an established 
cohort 
1.71 Fried 14% 
McAdams-
DeMarco et al 
201334 
N = 95 
%female = 46 
Mean age = 61 
years (+/- 12.6) 
Single dialysis centre 
HD% = 100 
USA 
Association of frailty with risk of falls in 
patients with ESKD 
Primary 
prospective study 
1.71 Fried 46.3% 
Orlandi et al 
201417 
N = 60 
%female = 30 
Mean age = 71 
years (+/- 6.9) 
Single dialysis centre 
HD% = 100 
Brazil 
Assessment of frailty in elderly patients 
undergoing dialysis  
Primary 
prospective study 
1.10 Edmonton 
Frailty scale 
38% 
Salter et al 
201544 
 
N = 146 
%female = 46.6 
Mean age = 61 
years 
Single dialysis centre 
HD% = 100 
USA 
Comparison between measured frailty 
and clinician perceived frailty 
Primary 
prospective study 
1.71 Fried 41.7% 
Chao et al 
201545 
N = 46 
%female = 53 
Mean age = 67.3 
(+/- 11.9) years 
Single dialysis centre 
HD% = 100 
Taiwan 
 
Exploring frailty in a rural dialysis 
centre in Taipei and comparison 
between different self-reported 
measures of Frailty. 
Primary 
prospective study 
1.52 FRAIL scale 
amongst others.  
19.6% 
Alfaadhel et al 
201532 
N = 390 
%female = 33 
Mean age = 63 
years (+/- 15)  
 
Single dialysis centre 
HD% = 100 
USA 
Assessed whether the clinicians 
perception of frailty correlated with 
outcomes in a population of patients 
on dialysis. 
Primary 
prospective study 
1.81 Clinical frailty 
scale 
26% 
Iyasere et al 
201646 
N = 251 
%female = 40.7 
Median age = 76 
(70-81 years IQR) 
Single Dialysis Centre 
HD% = 48.6 
UK 
Comparison of frailty and quality of life 
between patients on haemodialysis 
with those on peritoneal dialysis. 
Cross sectional analysis  
Primary 
prospective study 
1.57 Clinical frailty 
scale 
47.4% 
(overall) 
McAdams- 
DeMarco et al 
201547 
N = 324 
%female = 43.5 
Mean age = 54.8  
Predictors of arrhythmic 
and cardiovascular risk in 
ESKD Study.  
Investigated the relationship between 
frailty and cognition both at base line 
and at one year of follow up. 
Secondary analysis 
of an established 
cohort 
1.76 Fried  34% 
  
years (+/- 13.3) HD% = 100 
USA 
Prospective cohort study 
Drost et al 
201648 
N = 95 
%female = 43 
Mean age = 65.2 
years (+/- 12) 
Single dialysis centre 
HD% = 44 
Netherlands 
Comparison between prevalence of 
frailty assessed using the frailty index 
versus the Fried Frailty Phenotype. 
Cross sectional analysis 
Primary 
prospective Study 
1.76 Fried and Frailty 
Index 
36.8% 
(measured 
using FI) 
 
 
 
 
 
 
 
 
 
 
  
Table 3: Fried Frailty Assessment  
Original Definition of the Fried Phenotype by Fried 
et al (5) 
Interpretation of Fried Phenotype (n=23) 
Slowness 
Gait speed 
Gait speed (n=17, 74%) 
Questionnaire based assessment of physical function (n=5) 
Subjective perception of gait speed (n=1) 
Weakness 
Grip Strength 
Dyno metre measurement of grip strength (n=14, 61%) 
Questionnaire based assessment of physical function (n=5) 
Timed sit-to-stand (n=2) 
Self-report (n=2)  
Exhaustion 
Centre for epidemiological studies depression 
scale 
Patient self-report (n=11, 48%) 
Centre for Epidemiological Studies depression scale (n=5) 
Short form 36 Questionnaire (n=6) 
Short form 12 Questionnaire (n=1) 
Shrinkage 
>10 pounds of unintentional weight loss in 12 
months 
Weight loss of 10 pounds over 12 months (n=12, 52%) 
Other measures of weight loss (BMI, 5% loss in total weight, lean appendicular mass, cachexia) 
(n=9, 39%) 
Not measured (n=2) 
Low Physical Activity 
Estimated kilocalories per week 
Estimation of kilocalories (n=9, 39%) 
Patient self-report (n=8) 
Questionnaire based physical activities scale (n=6) 
 
 
